CN Patent

CN114621127A — 一种取代二氢吡咯的合成方法

Assigned to Suzhou Pengxu Pharmatech Co ltd · Expires 2022-06-14 · 4y expired

What this patent protects

本申请提供一种取代二氢吡咯的合成方法。更进一步，式I化合物经催化剂的催化偶联合成的式II化合物，再经酯水解反应得到式III化合物。所述取代二氢吡咯的合成方法合成流程简单，后处理方便，易于工业化生产。

USPTO Abstract

本申请提供一种取代二氢吡咯的合成方法。更进一步，式I化合物经催化剂的催化偶联合成的式II化合物，再经酯水解反应得到式III化合物。所述取代二氢吡咯的合成方法合成流程简单，后处理方便，易于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN114621127A
Jurisdiction
CN
Classification
—
Expires
2022-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Pengxu Pharmatech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.